{"id":"https://openalex.org/W2723308302","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9041","title":"First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).","display_name":"First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2723308302","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9041","mag":"2723308302"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.9041","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9041","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9041","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100709250","display_name":"Yuankai Shi","orcid":"https://orcid.org/0000-0002-3342-4964","observed_orcids":["https://orcid.org/0000-0002-3342-4964"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210141458","display_name":"Cancer Hospital of Chinese Academy of Medical Sciences","ror":"https://ror.org/03x937183","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141458"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuankai Shi","raw_affiliation_strings":["Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China;","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210141458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115695074","display_name":"Lin Wang","orcid":"https://orcid.org/0009-0007-0224-3515","observed_orcids":["https://orcid.org/0009-0007-0224-3515"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lin Wang","raw_affiliation_strings":["Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China;","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021139793","display_name":"Baohui Han","orcid":"https://orcid.org/0000-0002-3950-3030","observed_orcids":["https://orcid.org/0000-0002-3950-3030"]},"institutions":[{"id":"https://openalex.org/I2802608112","display_name":"Shanghai Chest Hospital","ror":"https://ror.org/03fjc3817","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802608112"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Baohui Han","raw_affiliation_strings":["Shanghai Chest Hospital, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Chest Hospital, Shanghai, China;","institution_ids":["https://openalex.org/I2802608112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[{"id":"https://openalex.org/I194450716","display_name":"Jilin University","ror":"https://ror.org/00js3aw79","country_code":"CN","type":"education","lineage":["https://openalex.org/I194450716"]},{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["First Hospital Affiliated to Jilin University, Jilin, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Hospital Affiliated to Jilin University, Jilin, China;","institution_ids":["https://openalex.org/I194450716","https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102375112","display_name":"Ping Yu","orcid":"https://orcid.org/0009-0008-3697-0857","observed_orcids":["https://orcid.org/0009-0008-3697-0857"]},"institutions":[{"id":"https://openalex.org/I4210118556","display_name":"Sichuan Cancer Hospital","ror":"https://ror.org/029wq9x81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118556"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ping Yu","raw_affiliation_strings":["Department of Lung Cancer Medical Oncology, Sichuan Cancer Hospital, Chengdu, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lung Cancer Medical Oncology, Sichuan Cancer Hospital, Chengdu, China;","institution_ids":["https://openalex.org/I4210118556"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108058498","display_name":"Yunpeng Liu","orcid":"https://orcid.org/0000-0002-0959-0209","observed_orcids":["https://orcid.org/0000-0002-0959-0209"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yunpeng Liu","raw_affiliation_strings":["Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China;","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103403366","display_name":"Cuimin Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106405","display_name":"Fourth Hospital of Hebei Medical University","ror":"https://ror.org/01mdjbm03","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106405"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Cuimin Ding","raw_affiliation_strings":["Tumor Hospital Of Hebei Province, Shijiazhuang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumor Hospital Of Hebei Province, Shijiazhuang, China;","institution_ids":["https://openalex.org/I4210106405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101359965","display_name":"Song Xia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102673","display_name":"Shanxi Provincial Cancer Hospital","ror":"https://ror.org/01790dx02","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210102673"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xia Song","raw_affiliation_strings":["Shanxi Provincial Tumor Hospital, Taiyuan, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanxi Provincial Tumor Hospital, Taiyuan, China;","institution_ids":["https://openalex.org/I4210102673"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100965309","display_name":"Ma Zhi Yong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143608","display_name":"Henan Cancer Hospital","ror":"https://ror.org/043ek5g31","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210143608"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ma Zhi Yong","raw_affiliation_strings":["Henan Cancer Hospital, Zhengzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henan Cancer Hospital, Zhengzhou, China;","institution_ids":["https://openalex.org/I4210143608"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101089170","display_name":"Xinling Ren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158926","display_name":"Xijing Hospital","ror":"https://ror.org/05cqe9350","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinling Ren","raw_affiliation_strings":["Xijing Hospital, Xian, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xijing Hospital, Xian, China;","institution_ids":["https://openalex.org/I4210158926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102745348","display_name":"J. Feng","orcid":"https://orcid.org/0000-0003-2805-6818","observed_orcids":["https://orcid.org/0000-0003-2805-6818"]},"institutions":[{"id":"https://openalex.org/I4210128482","display_name":"Jiangsu Cancer Hospital","ror":"https://ror.org/03108sf43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210128482"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ji Feng Feng","raw_affiliation_strings":["China Jinagsu Province Inst of Cancer Rsrch, Jiangsu, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"China Jinagsu Province Inst of Cancer Rsrch, Jiangsu, China;","institution_ids":["https://openalex.org/I4210128482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023128001","display_name":"Helong Zhang","orcid":"https://orcid.org/0000-0001-8430-6071","observed_orcids":["https://orcid.org/0000-0001-8430-6071"]},"institutions":[{"id":"https://openalex.org/I4210154136","display_name":"Tang Du Hospital","ror":"https://ror.org/04yvdan45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154136"]},{"id":"https://openalex.org/I9916479","display_name":"Air Force Medical University","ror":"https://ror.org/00ms48f15","country_code":"CN","type":"education","lineage":["https://openalex.org/I9916479"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Helong Zhang","raw_affiliation_strings":["Tangdu Hospital, Fourth Military Medical University, Xi'an, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tangdu Hospital, Fourth Military Medical University, Xi'an, China;","institution_ids":["https://openalex.org/I4210154136","https://openalex.org/I9916479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056574511","display_name":"Gongyan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I156144747","display_name":"Harbin Medical University","ror":"https://ror.org/05jscf583","country_code":"CN","type":"education","lineage":["https://openalex.org/I156144747"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Gongyan Chen","raw_affiliation_strings":["The Affiliated Tumor Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Affiliated Tumor Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China;","institution_ids":["https://openalex.org/I156144747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101699803","display_name":"Ning Wu","orcid":"https://orcid.org/0000-0001-6971-2995","observed_orcids":["https://orcid.org/0000-0001-6971-2995","https://orcid.org/0009-0008-7974-9474"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Wu","raw_affiliation_strings":["Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China;","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008382997","display_name":"Xiaohong Han","orcid":"https://orcid.org/0000-0001-9190-0167","observed_orcids":["https://orcid.org/0000-0001-9190-0167"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaohong Han","raw_affiliation_strings":["Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China;","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100687220","display_name":"Chen Yao","orcid":"https://orcid.org/0000-0003-4224-5535","observed_orcids":["https://orcid.org/0000-0003-4224-5535","https://orcid.org/0000-0002-4916-4204"]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chen Yao","raw_affiliation_strings":["Peking University Clinical Research Institute, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University Clinical Research Institute, Beijing, China;","institution_ids":["https://openalex.org/I20231570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101506974","display_name":"Yong Song","orcid":"https://orcid.org/0000-0002-8601-4264","observed_orcids":["https://orcid.org/0000-0002-8601-4264"]},"institutions":[{"id":"https://openalex.org/I2799773085","display_name":"Nanjing General Hospital of Nanjing Military Command","ror":"https://ror.org/04kmpyd03","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2799773085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yong Song","raw_affiliation_strings":["Nanjing Military General Hospital, Nanjing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanjing Military General Hospital, Nanjing, China;","institution_ids":["https://openalex.org/I2799773085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101443245","display_name":"Shucai Zhang","orcid":"https://orcid.org/0000-0001-6979-0598","observed_orcids":["https://orcid.org/0000-0001-6979-0598"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210107581","display_name":"Beijing Chest Hospital","ror":"https://ror.org/01espdw89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210107581"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shucai Zhang","raw_affiliation_strings":["Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China;","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210107581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102521513","display_name":"Lieming Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096731","display_name":"Betta Pharmaceuticals (China)","ror":"https://ror.org/00tf10278","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096731"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lieming Ding","raw_affiliation_strings":["Betta Pharmaceuticals Co.,Ltd., Hangzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Betta Pharmaceuticals Co.,Ltd., Hangzhou, China;","institution_ids":["https://openalex.org/I4210096731"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032952436","display_name":"Fenlai Tan","orcid":"https://orcid.org/0009-0002-7289-3218","observed_orcids":["https://orcid.org/0009-0002-7289-3218"]},"institutions":[{"id":"https://openalex.org/I4210166576","display_name":"First Affiliated Hospital Zhejiang University","ror":"https://ror.org/05m1p5x56","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166576"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fenlai Tan","raw_affiliation_strings":["The 1st Affiliated Hospital, Hangzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The 1st Affiliated Hospital, Hangzhou, China;","institution_ids":["https://openalex.org/I4210166576"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":21,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"9041","last_page":"9041"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/icotinib","display_name":"icotinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.796999990940094},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9900000095367432},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9380000233650208},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/convince-trial","display_name":"CONVINCE trial","score":0.7070000171661377},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5929999947547913},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.5509999990463257},{"id":"https://openalex.org/keywords/tumor-response-rate","display_name":"tumor response rate","score":0.6190000176429749},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.3869999945163727},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.908611536026001},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.9033781290054321},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7227966785430908},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.6189388036727905},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.603961706161499},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6038748025894165},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.525384247303009},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.5121026039123535},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.47632938623428345},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4753432273864746},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.45281001925468445},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.448220819234848},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2978397607803345},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2779412865638733},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.09524789452552795}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.9041","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9041","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9041","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2747505649","https://openalex.org/W2588327324","https://openalex.org/W2977016055","https://openalex.org/W2280688865","https://openalex.org/W3186743916","https://openalex.org/W4254215803","https://openalex.org/W3083757824","https://openalex.org/W2382533078","https://openalex.org/W2210888173","https://openalex.org/W2269546899"],"abstract_inverted_index":{"9041":[0],"Background:":[1],"Icotinib":[2,183,209],"is":[3,17,275],"an":[4],"oral,":[5],"selective":[6],"epidermal":[7],"growth":[8],"factor":[9],"receptor":[10],"tyrosine":[11],"kinase":[12],"inhibitor":[13],"(EGFR":[14],"TKI),":[15],"which":[16,156],"non-inferior":[18],"to":[19,79,105,152],"gefitinib":[20],"in":[21,42,63,155,229,254,269,289],"treating":[22],"unselected":[23],"or":[24,87,118],"EGFR-mutated":[25],"advanced":[26],"non-small":[27],"cell":[28],"lung":[29,43,69,290],"cancer":[30],"(NSCLC)":[31],"patients":[32,45,66,100,147,168,292],"as":[33,39,112],"second-line":[34],"therapy.":[35],"We":[36],"assess":[37],"icotinib":[38,81,231,255,274],"first-line":[40],"therapy":[41,114,288],"adenocarcinoma":[44,291],"with":[46,205,283,293],"EGFR":[47,72,295],"mutation.":[48,296],"Methods:":[49],"This":[50],"phase":[51],"3,":[52],"open-label,":[53],"randomized":[54,78,161],"study":[55],"(CONVINCE,":[56],"NCT01719536)":[57],"was":[58,122,137],"conducted":[59],"at":[60],"18":[61],"sites":[62],"China.":[64],"Eligible":[65],"(pathologically":[67],"confirmed":[68],"adenocarcinoma,":[70],"19/21":[71],"mutation,":[73],"treatment":[74],"naive)":[75],"were":[76,148,158,169,178,227,245,257],"1:1":[77],"receive":[80,106],"(125":[82],"mg,":[83],"three":[84],"times":[85],"daily)":[86],"pemetrexed":[88,107,286],"(500":[89,108],"mg/m2,":[90,96,109],"day":[91,97,110],"1)":[92,111],"plus":[93,285],"cisplatine":[94],"(75":[95],"1),":[98],"non-progressive":[99],"after":[101],"4-cycle":[102],"chemotherapy":[103,207,270],"continue":[104],"maintenance":[113,287],"until":[115],"disease":[116,129],"progression":[117,138],"intolerable":[119],"toxicity.":[120],"Randomization":[121],"stratified":[123],"by":[124],"performance":[125],"status,":[126,128],"smoking":[127],"stage,":[130],"and":[131,145,160,166,251,278],"mutation":[132],"type.":[133],"The":[134,241],"primary":[135],"endpoint":[136],"free":[139],"survival":[140],"(PFS).":[141],"Results:":[142],"Six":[143],"hundred":[144],"sixty-nine":[146],"screened":[149],"(January,":[150],"2013":[151],"August,":[153],"2014),":[154],"296":[157],"enrolled":[159],"(148":[162],"for":[163],"each":[164],"group),":[165],"285":[167],"treated":[170],"(icotinib:":[171],"148,":[172],"chemotherapy:":[173],"137).":[174],"Baseline":[175],"patients\u2019":[176],"characteristics":[177],"well":[179,276],"balanced":[180],"between":[181],"groups.":[182],"significantly":[184],"improved":[185],"PFS":[186,281],"(296":[187],"days":[188,194],"[95%":[189],"CI":[190,199],"255\u2013355]":[191],"vs":[192,217,235],"219":[193],"[189\u2013253];":[195],"HR":[196],"0.67,":[197],"95%":[198],"0.49-0.90,":[200],"p":[201,219,238],"=":[202],"0.008)":[203],"compared":[204,282],"the":[206,230],"group.":[208,271],"also":[210],"showed":[211],"better":[212],"tumor":[213],"response":[214],"rate":[215],"(64.8%":[216],"33.8%,":[218],"<":[220,239],"0.001).":[221,240],"Significantly":[222],"fewer":[223],"adverse":[224],"events":[225],"(AEs)":[226],"seen":[228],"group":[232],"(104":[233],"[70.3%]":[234],"121":[236],"[88.3%],":[237],"most":[242],"common":[243],"AEs":[244],"elevated":[246,266],"transaminase":[247,267],"(29.1%),":[248],"rash":[249],"(17.6%)":[250],"diarrhea":[252],"(9.5%)":[253],"group,and":[256],"neutropenia":[258],"(77.4%),":[259],"erythropenia":[260],"(76.6%),":[261],"leukopenia":[262],"(70.1%),":[263],"nausea":[264],"(54.7%),":[265],"(40.1%)":[268],"Conclusions:":[272],"First-line":[273],"tolerated":[277],"offers":[279],"superior":[280],"cisplatine/pemetrexed":[284],"sensitizing":[294],"Clinical":[297],"trial":[298],"information:":[299],"NCT01719536.":[300]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2017-06-30T00:00:00"}